Jasper Hellweg
Stock Analyst at Argus Research
(2.08)
# 2,986
Out of 5,140 analysts
91
Total ratings
47.89%
Success rate
3.64%
Average return
Main Sectors:
Stocks Rated by Jasper Hellweg
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BAX Baxter International | Downgrades: Hold | n/a | $19.71 | - | 3 | Oct 31, 2025 | |
| ZTS Zoetis | Reiterates: Buy | $190 | $125.08 | +51.90% | 7 | Sep 9, 2025 | |
| BIIB Biogen | Downgrades: Hold | n/a | $172.62 | - | 4 | Apr 4, 2025 | |
| UTHR United Therapeutics | Maintains: Buy | $360 → $400 | $469.77 | -14.85% | 7 | Oct 31, 2024 | |
| ILMN Illumina | Upgrades: Buy | $150 | $152.48 | -1.63% | 7 | Aug 28, 2024 | |
| SNY Sanofi | Maintains: Buy | $55 → $60 | $46.18 | +29.93% | 2 | Jul 26, 2024 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $1,060 → $1,170 | $749.33 | +56.14% | 9 | Jun 25, 2024 | |
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $465 → $550 | $461.14 | +19.27% | 7 | Jun 17, 2024 | |
| AZN AstraZeneca | Maintains: Buy | $80 → $85 | $90.54 | -6.12% | 3 | May 30, 2024 | |
| NVO Novo Nordisk | Maintains: Buy | $115 → $125 | $59.32 | +110.72% | 1 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $140 | $49.81 | +181.07% | 4 | Sep 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $216.15 | - | 2 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $31.41 | - | 1 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $260 → $290 | $241.40 | +20.13% | 4 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $100 | $87.00 | +14.94% | 3 | Jun 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $270 → $295 | $269.14 | +9.61% | 4 | May 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $11.50 | - | 3 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $135 | $184.65 | -26.89% | 5 | Oct 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $14.91 | - | 2 | Apr 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $212.01 | - | 3 | Apr 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $199.51 | - | 2 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $30.35 | - | 4 | Oct 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $155 | $465.44 | -66.70% | 3 | Nov 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $90 | $65.73 | +36.92% | 1 | Sep 19, 2018 |
Baxter International
Oct 31, 2025
Downgrades: Hold
Price Target: n/a
Current: $19.71
Upside: -
Zoetis
Sep 9, 2025
Reiterates: Buy
Price Target: $190
Current: $125.08
Upside: +51.90%
Biogen
Apr 4, 2025
Downgrades: Hold
Price Target: n/a
Current: $172.62
Upside: -
United Therapeutics
Oct 31, 2024
Maintains: Buy
Price Target: $360 → $400
Current: $469.77
Upside: -14.85%
Illumina
Aug 28, 2024
Upgrades: Buy
Price Target: $150
Current: $152.48
Upside: -1.63%
Sanofi
Jul 26, 2024
Maintains: Buy
Price Target: $55 → $60
Current: $46.18
Upside: +29.93%
Regeneron Pharmaceuticals
Jun 25, 2024
Maintains: Buy
Price Target: $1,060 → $1,170
Current: $749.33
Upside: +56.14%
Vertex Pharmaceuticals
Jun 17, 2024
Maintains: Buy
Price Target: $465 → $550
Current: $461.14
Upside: +19.27%
AstraZeneca
May 30, 2024
Maintains: Buy
Price Target: $80 → $85
Current: $90.54
Upside: -6.12%
Novo Nordisk
Feb 1, 2024
Maintains: Buy
Price Target: $115 → $125
Current: $59.32
Upside: +110.72%
Sep 13, 2023
Maintains: Buy
Price Target: $160 → $140
Current: $49.81
Upside: +181.07%
Apr 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $216.15
Upside: -
Jan 27, 2022
Downgrades: Hold
Price Target: n/a
Current: $31.41
Upside: -
Sep 10, 2021
Maintains: Buy
Price Target: $260 → $290
Current: $241.40
Upside: +20.13%
Jun 9, 2021
Upgrades: Buy
Price Target: $100
Current: $87.00
Upside: +14.94%
May 20, 2021
Maintains: Buy
Price Target: $270 → $295
Current: $269.14
Upside: +9.61%
May 5, 2021
Downgrades: Hold
Price Target: n/a
Current: $11.50
Upside: -
Oct 21, 2020
Upgrades: Buy
Price Target: $135
Current: $184.65
Upside: -26.89%
Apr 17, 2020
Downgrades: Hold
Price Target: n/a
Current: $14.91
Upside: -
Apr 6, 2020
Downgrades: Hold
Price Target: n/a
Current: $212.01
Upside: -
Mar 24, 2020
Downgrades: Hold
Price Target: n/a
Current: $199.51
Upside: -
Oct 30, 2019
Downgrades: Hold
Price Target: n/a
Current: $30.35
Upside: -
Nov 6, 2018
Maintains: Buy
Price Target: $150 → $155
Current: $465.44
Upside: -66.70%
Sep 19, 2018
Maintains: Buy
Price Target: $85 → $90
Current: $65.73
Upside: +36.92%